non glp 1 weight loss drugs π¨ GLP-1 DRUGS: A BREAKTHROUGH OR A NEW RISK? π€π, π₯ βThe Hidden Side of GLP-1s: Could Weight Loss Trigger Eating Disorders?β π₯, GLP-1 medications such as semaglutide and tirzepatide Market Overview: GLP-1 Agonists and
Description
While these alternatives may offer benefits such as improved insulin sensitivity, insulin release, and decreased blood sugar levels, they may also have side effects

Overall, the latest human data on GLP-1 drugs and thyroid cancer risk have not demonstrated a clear causal link between GLP-1 therapy and increased medullary thyroid carcinoma rates

Its whether theyre being prescribed safely, supported appropriately, and offered by companies that put long-term patient health above short-term growth

Sanyal, P

doi:10.1210/er.2015-1084 9

W., Kollman, C., Barnes-Lomen, V., Sulik, M., Haller, M